Racial, Ethnic Disparities Persist in Asthma Inhaler Use
A study of over 1.1 million American adults with asthma found that Black, Hispanic, and Asian patients use ICS, LABA and LAMA inhalers less frequently than white patients.
Tag: asthma adult care
All
Latest
Racial, Ethnic Disparities Persist in Asthma Inhaler Use
A study of over 1.1 million American adults with asthma found that Black, Hispanic, and Asian patients use ICS, LABA and LAMA inhalers less frequently than white patients.
Read More
Tezepelumab Reduced Asthma Attacks
A new study shows tezepelumab (Tezspire) reduced asthma exacerbations by 70% across all patient subgroups, including smokers and those with comorbid conditions.
Read More
Asthma Risk and Ultra-processed Foods
High consumption of ultra-processed food products significantly raises the likelihood of asthma onset in school-age children, according to a longitudinal study.
Read More
ATS Reports Urgent Need for Anti-inflammatory Inhaler Access
On World Asthma Day 2026, the American Thoracic Society and the Forum of International Respiratory Societies (FIRS) issued a call to action for universal access to anti-inflammatory inhalers.
Read More
Severe Asthma Nearly Doubles Risk of Premature Death
A 20-year study of 11,000 patients shows that comorbidities and frequent exacerbations drive higher mortality rates in severe asthma cases.
Read More
Nanoparticles Retrain Immune System to Treat Asthma
Researchers are testing biodegradable particles designed to induce allergen tolerance without the need for broad immunosuppressive medications.
Read More
WHO Expands Asthma Care in Nepal, Sri Lanka
The initiative focuses on integrating respiratory services into primary healthcare to improve diagnosis and treatment access.
Read More
Protein Pathway Linked to Asthma Airway Inflammation
Targeting molecular switches in specialized lung cells may provide a new approach to preventing complications from allergic airway diseases.
Read More
Allergy-Asthma Management Strategies
The American College of Allergy, Asthma and Immunology emphasizes the link between uncontrolled allergies and asthma flares.
Read More
Comorbidity ‘Clusters’ for Severe Asthma
Researchers identified three stable clusters of coexisting conditions that influence disease severity and treatment needs for patients with severe asthma.
Read More
FDA, EMA Accept Filings for Teva Xolair Biosimilar
The US FDA and the European Medicines Agency (EMA) accepted regulatory filings for Teva Pharma’s biosimilar candidate to Xolair (omalizumab).
Read More
Rademikibart Tied to Rapid Lung Function Improvement in Asthma, COPD
Phase 1 study revealed significant FEV1 improvements within 15 min of a single dose of IV rademikibart — an antibody targeting interleukin-4 receptor alpha.
Read More
Osteopathic Treatment May Improve Lung Function in Asthma Patients
A systematic review suggests that osteopathic manipulative treatment may help address respiratory mechanical dysfunctions and improve objective pulmonary outcomes in asthma care.
Read More
Reduced Dampness in Homes Linked to Less Respiratory Medication Use
Reducing dampness through insulation and ventilation improvements can lead to measurable reductions in asthma treatments, particularly for pediatric populations.
Read More
Asthma in Older Adults Linked to Undertreatment, Lower QoL
Asthma in adults over age 60 remains significantly undertreated, leading to poorer disease control and diminished quality of life, particularly in patients over 80.
Read More
pMDI, CRISPR Inventors to Join National Inventors Hall of Fame
Maison, Porush & Theil — inventors of the pressure metered dose inhaler (pMDI) — will be posthumously inducted into the National Inventors Hall of Fame in May 2026.
Read More
FDA Approves First Flovent Generic for Asthma
The generic Flovent HFA (fluticasone propionate) inhalation aerosol is approved as a maintenance therapy for asthma in patients aged 4 years and older.
Read More
Biologics Underprescribed for Obesity-linked Asthma
Respiratory biologics were prescribed to only 11.9% of eligible overweight or obese patients with asthma.
Read More
Asthma Biologics Not Tied to Increased Respiratory Infections
Biologics including Dupilumab and anti-IL-5 agents were associated with a lower probability of pneumonia within the study.
Read More
Mediterranean Diet Linked to Lower Adult-Onset Asthma Risk
Researchers revealed a significant inverse association between Mediterranean diet adherence and adult-onset asthma risk.
Read More
Mold Intervention in Public Housing Reduced ED Asthma Visits
A mold reduction initiative in New York City resulted in 2,798 fewer emergency department visits per year for asthma exacerbation.
Read More
GLP-1s Tied to Reduced Asthma Exacerbation in Obese Patients
GLP-1 initiation is associated with a 14.6% reduced risk of asthma exacerbation for overweight patients, 12.2% for obese patients and 13.3% for morbidly obese patients.
Read More
ICI Therapy May Reduce Asthma Exacerbations
Patients receiving Immune checkpoint inhibitors (ICI) pembrolizumab or nivolumab exhibited a modest reduction in asthma exacerbation rates at 24 months.
Read More
Positive Ph3 Trial Data Treating Uncontrolled Asthma with Breztri
AstraZeneca’s Breztri Aerosphere demonstrated statistically significant and clinically meaningful improvements in patients with uncontrolled asthma compared with other pharmacology.
Read More